Reports that despite $1.15 billion in NIH RECOVER funding since 2020, no FDA-approved treatments exist for long COVID, leaving many of the estimated 17 million affected U.S. adults without options. Patient advocates argue the program prioritized observational research over clinical trials, delaying the path to actual care.
Experts & Clinics
Long-Covid Patients Are Frustrated That Federal Research Hasn't Found New Treatments
January 22, 2025
Despite $1.15 billion in NIH RECOVER funding, no FDA-approved treatments exist, and advocates argue the program prioritized observation over trials.
Save For Later
Email yourself a link to this article.
Saved. Check your email app.
Something didn't go through — try again.